|
|
||||||||
Eur J Cardiothorac Surg 1998;13:365-369
© 1998 Elsevier Science NL
a Department of Thoracic and Cardiac Surgery, -414-, University Hospital Nijmegen, Nijmegen P.O. Box 9101, 6500, Netherlands
b Department of Medical Informatics, Epidemiology and Statistics, -152-, University Nijmegen, Nijmegen P.O. Box 9101, 6500, Netherlands
Received 24 November 1997; received in revised form 26 January 1998; accepted 4 February 1998.
Corresponding author. Tel.: +24 3614744; fax: +24 3540129; e-mail: L.Noyez@thchir.azn.nl
Objective: The patient population undergoing myocardial revascularization has changed during the last few years. Knowledge of these changes, and of the subsequent influence on morbidity and/or mortality is important, not only for up-dating quality control, but also to support decision-making in financial and economical aspects, and in further research concerning coronary artery surgery. Methods: Pre-, per- and postoperative data of 3834 primary isolated coronary bypass operations, January 1987December 1995 were analyzed. The total group was divided into three time cohorts. Group A: 19871989 (n=1292); group B: 19901992 (n=1130); and group C: 19931995 (n=1412). Results: Mean age increased from 60.4±9.0 (S.D.) years in group A to 62.9±9.9 (S.D.) years in group C (P<0.0005). Patients with insulin-dependent diabetic (P=0.005), uro-nefrological (P=0.002), pulmonary (P<0.0005)and neurological (P=0.003) pathology increased significantly, and there was a significant increase in the use of arterial grafts (P<0.05). Postoperative, hospital mortality remained stable (±2.5%). However, there was a significant increasing percentage of patients with pulmonary (P=0.04), neurological (P=0.02) and uro-nefrological (P<0.0005) problems. Conclusion: During the last few years there has been a trend in myocardial revascularization of older patients, with more coexisting disease. Despite the fact that hospital mortality seems stable, there is an increase in major postoperative morbidity.
Key Words: Myocardial revascularization Comorbidity Mortality Morbidity
This article has been cited by other articles:
![]() |
F. M. van Eck, L. Noyez, F. W.A. Verheugt, and R. M.H.J. Brouwer Changing profile of patients undergoing redo-coronary artery surgery Eur. J. Cardiothorac. Surg., February 1, 2002; 21(2): 205 - 211. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Noyez, J. A.M. van Druten, J. Mulder, A. M.A. Schroen, S. H. Skotnicki, and R. M.H.J. Brouwer Sternal wound complications after primary isolated myocardial revascularization: the importance of the post-operative variables Eur. J. Cardiothorac. Surg., April 1, 2001; 19(4): 471 - 476. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Zaman, R. A. Archbold, G. Helft, E. A. Paul, N. P. Curzen, and P. G. Mills Atrial Fibrillation After Coronary Artery Bypass Surgery : A Model for Preoperative Risk Stratification Circulation, March 28, 2000; 101(12): 1403 - 1408. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kuhn, U. Muller-Werdan, D.V. Schmitt, H. Lange, G. Pilz, E. Kreuzer, F.W. Mohr, H.-R. Zerkowski, and K. Werdan Improved outcome of APACHE II score-defined escalating systemic inflammatory response syndrome in patients post cardiac surgery in 1996 compared to 1988-1990: the ESSICS-study pilot project Eur. J. Cardiothorac. Surg., January 1, 2000; 17(1): 30 - 37. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P.B. Janssen, L. Noyez, J. A.M. van Druten, S. H. Skotnicki, and L. K. Lacquet Predictors of neurological morbidity after coronary artery bypass surgery Eur. J. Cardiothorac. Surg., February 1, 1999; 15(2): 166 - 172. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. D. Loop Coronary artery surgery: the end of the beginning Eur. J. Cardiothorac. Surg., December 1, 1998; 14(6): 554 - 571. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |